HRP20120177T1 - Otopina za peritonealnu dijalizu koja sadrži karnitin, s poboljšanom biokompatibilnošću - Google Patents

Otopina za peritonealnu dijalizu koja sadrži karnitin, s poboljšanom biokompatibilnošću Download PDF

Info

Publication number
HRP20120177T1
HRP20120177T1 HR20120177T HRP20120177T HRP20120177T1 HR P20120177 T1 HRP20120177 T1 HR P20120177T1 HR 20120177 T HR20120177 T HR 20120177T HR P20120177 T HRP20120177 T HR P20120177T HR P20120177 T1 HRP20120177 T1 HR P20120177T1
Authority
HR
Croatia
Prior art keywords
solution according
acid
vol
meq
carnitine
Prior art date
Application number
HR20120177T
Other languages
English (en)
Croatian (hr)
Inventor
Arduini Arduino
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of HRP20120177T1 publication Critical patent/HRP20120177T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
HR20120177T 2005-03-10 2006-02-22 Otopina za peritonealnu dijalizu koja sadrži karnitin, s poboljšanom biokompatibilnošću HRP20120177T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2005000130 2005-03-10
PCT/EP2006/060162 WO2006094900A1 (en) 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility

Publications (1)

Publication Number Publication Date
HRP20120177T1 true HRP20120177T1 (hr) 2012-03-31

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120177T HRP20120177T1 (hr) 2005-03-10 2006-02-22 Otopina za peritonealnu dijalizu koja sadrži karnitin, s poboljšanom biokompatibilnošću

Country Status (19)

Country Link
US (1) US20080138443A1 (enExample)
EP (1) EP1858504B1 (enExample)
JP (2) JP4717110B2 (enExample)
KR (1) KR101324920B1 (enExample)
AR (1) AR054015A1 (enExample)
AT (1) ATE539742T1 (enExample)
CA (1) CA2599252C (enExample)
CY (1) CY1112794T1 (enExample)
DK (1) DK1858504T3 (enExample)
ES (1) ES2380168T3 (enExample)
HR (1) HRP20120177T1 (enExample)
ME (1) ME02948B (enExample)
MX (1) MX2007010814A (enExample)
PL (1) PL1858504T3 (enExample)
PT (1) PT1858504E (enExample)
RS (1) RS52237B (enExample)
SI (1) SI1858504T1 (enExample)
TW (1) TWI388318B (enExample)
WO (1) WO2006094900A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
WO2018031922A1 (en) * 2016-08-11 2018-02-15 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) * 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
US6537976B1 (en) 1997-08-07 2003-03-25 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
KR100642731B1 (ko) * 1999-10-11 2006-11-03 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 의료용 용액에서 삼투제로서 ｌ-카르니틴 및 그의알카노일 유도체의 용도
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
CA2508596A1 (en) 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
RS52237B (sr) 2012-10-31
DK1858504T3 (da) 2012-04-30
PT1858504E (pt) 2012-04-10
CA2599252C (en) 2013-07-30
SI1858504T1 (sl) 2012-04-30
JP2010207630A (ja) 2010-09-24
CA2599252A1 (en) 2006-09-14
TW200714279A (en) 2007-04-16
KR20070116630A (ko) 2007-12-10
EP1858504A1 (en) 2007-11-28
ES2380168T3 (es) 2012-05-09
WO2006094900A1 (en) 2006-09-14
US20080138443A1 (en) 2008-06-12
ATE539742T1 (de) 2012-01-15
MX2007010814A (es) 2007-11-07
EP1858504B1 (en) 2012-01-04
PL1858504T3 (pl) 2012-05-31
KR101324920B1 (ko) 2013-11-01
AR054015A1 (es) 2007-05-30
JP4717110B2 (ja) 2011-07-06
CY1112794T1 (el) 2016-02-10
JP2008532601A (ja) 2008-08-21
ME02948B (me) 2012-10-31
JP5366894B2 (ja) 2013-12-11
TWI388318B (zh) 2013-03-11

Similar Documents

Publication Publication Date Title
ES2850998T3 (es) Mezcla de ácidos carboxílicos para tratar pacientes con insuficiencia renal
JPH0322366B2 (enExample)
EA025137B1 (ru) Раствор для диализа, включающий одно или более соединений креатина и способ его получения
RU2008138266A (ru) Составы для парентерального введения лекарств и их применения
AU627041B2 (en) Improved nutritional formulation for the treatment of renal disease
WO1987003806A1 (en) Parenteral nutrition therapy with amino acids
ES2313616T3 (es) Utilizacion de las sales, de los compuestos de reaccion por adicion y de los compuestos complejos del acido guanidinoacetico.
EP1372676A1 (en) Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection
FI120080B (fi) Farmaseuttisia koostumuksia, joilla on antibioottinen vaikutus
CA2386826A1 (en) Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for peritoneal dialysis
JP2006506361A5 (enExample)
ES2416355T3 (es) Formulación líquida a base de un componente de ácido guanidinoacético
CA2535533A1 (en) Aqueous pharmaceutical solution comprising oxymetazoline and/or xylometazoline
JP2007501817A5 (enExample)
HRP20120177T1 (hr) Otopina za peritonealnu dijalizu koja sadrži karnitin, s poboljšanom biokompatibilnošću
JP5985456B2 (ja) 経口用組成物
EP2227221B1 (en) Effervescent tablets and effervescent granules containing carnitine tartrate
ES2622281T3 (es) Composiciones orales de calcitonina y sus aplicaciones
JP2008532601A5 (enExample)
ES2790948T3 (es) Solución de diálisis que comprende creatina para la protección celular
RU2002116377A (ru) Жидкие лечебные составы для внутривенного введения, содержащие декстрозу и инсулин
US3708574A (en) Pharmaceutical compositions providing potassium chloride in aqueous solution
BR112021015682A2 (pt) Combinação de silício e magnésio para a prevenção e tratamento contra cãibras musculares
US3822344A (en) Pharmaceutical compositions providing potassium chloride in aqueous solution
ITRM990483A1 (it) Composizione per la prevenzione e cura delle disfunzioni e patologie renali di tipo tossico e funzionale.